Celsion raises $6M to further heat-activated doxorubicin for primary liver cancer
07 July 2011
Nancy Faigen
Please Login to read the full article.
07 July 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Celsion still on track to take PhIII ThermoDox trial to final analysis at year end
- China's Hisun shifts gear to hi-tech and branded in alliances with Enzon and Celsion
- ImmunoGen to raise $84 million, adding own pipeline to Roche-licensed compounds
- Both Endocyte and Merck have much to gain from potential $1bn cancer alliance
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
